as on November 17, 2025 at 4:01 pm IST
Day's Low
Day's High
1.66%
Downside
7.51%
Upside
52 Week's Low
52 Week's High
27.97%
Downside
31.96%
Upside
as on November 17, 2025 at 4:01 pm IST
Market Cap
₹358.46 Cr
Return on Equity (ROE)
7.9
PE Ratio (TTM)
19.95
Return on capital employed (ROCE)
10.25
Industry PE ratio
42.22
Beta (LTM)
1.18
P/B Ratio
1.53
Dividend Yield
0PEG Ratio
284.99
Quarterly Earnings Growth YOY
2.61
EPS (TTM)
0.8
Sector
Pharmaceuticals
Book Value
7.96
Technical Analysis
Bullish
View Technical Analysis
as on November 17, 2025 at 4:01 pm IST
Gennex Laboratories Ltd in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (19.95x)
November 14, 2025
Industry (42.22x)
November 14, 2025
Highest (86.13x)
August 3, 2018
Today’s Price to Earnings Ratio: 19.95x
Compare market cap, revenue, PE, and other key metrics of Gennex Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 358.46 | 68.04% | 0.58 | 18 | 137 | |
| NA | 464.59 | 18.91% | 0.00 | 17 | 345 | |
| NA | 92.63 | -1.88% | 0.00 | 2 | 44 | |
| 2,564.39 | -9.15% | 0.72 | -567 | 1,283 | ||
| NA | 21,863.32 | 76.23% | 0.68 | -57 | 3,012 |
Investment in Gennex Laboratories Ltd Shares on INDmoney has dropped by -8.85% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Gennex Laboratories Ltd Stock has increased by 239% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:239% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Gennex Laboratories Ltd.
Gennex Laboratories Ltd’s net profit jumped 4.14% since last year same period to ₹5.03Cr in the Q2 2025-2026. On a quarterly growth basis, Gennex Laboratories Ltd has generated 9.59% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Gennex Lab. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 2.32 Cr → 5.03 Cr (in ₹), with an average increase of 29.1% per quarter
Price Rise
![]()
In the last 3 months, Gennex Lab. stock has moved up by 27.4%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 36.45 Cr → 39.3 Cr (in ₹), with an average increase of 7.3% per quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.4% return, outperforming this stock by 40.4%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.62% of holdings in Sep 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 76.38% of holdings in Sep 2025 quarter
| Organisation | Gennex Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | Arihant Baid |
| E-voting on shares | Click here to vote |
Gennex Laboratories Ltd share price today stands at ₹15.05 as on at the close of the market. Gennex Laboratories Ltd share today touched a day high of ₹16.18 and a low of ₹14.8.
Gennex Laboratories Ltd touched a 52 week high of ₹19.86 and a 52 week low of ₹10.84. Gennex Laboratories Ltd share price today i.e. is closed at ₹15.05, which is -24.22% down from its 52 week high and 38.84% up from its 52 week low.
Gennex Laboratories Ltd market capitalisation is ₹358.46 Cr as on .
To buy Gennex Laboratories Ltd shares, you need to follow these steps:
Gennex Laboratories Ltd trading volume is 6.99L as on . This means that 6.99L shares of Gennex Laboratories Ltd were bought and sold on the stock market during today's trading session.